Brian J. Caveney - Feb 2, 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, President of Diagnostics
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Brian J. Caveney
Stock symbol
LH
Transactions as of
Feb 2, 2023
Transactions value $
-$36,719
Form type
4
Date filed
2/6/2023, 02:41 PM
Previous filing
Nov 8, 2022
Next filing
Feb 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +443 +2.87% 15.9K Feb 2, 2023 Direct F1, F2
transaction LH Common Stock Tax liability -$36.7K -144 -0.91% $254.99 15.7K Feb 2, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -443 -16.3% $0.00 2.27K Feb 2, 2023 Common Stock 443 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Amount includes 20.9824 shares acquired on December 31, 2022 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
F3 Stock withholding to satisfy tax withholding obligations.
F4 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.